Biophagy’s Proprietary Drug Development

Biophagy is positioned as a discovery pharmaceutical company with a proprietary drug development program in anti-infectives and neurodegenerative disease. Its goal is to bring lead compounds into pre-clinical development and then to partner with a larger company for advanced testing and clinical trials.

Biophagy’s patented chemical libraries encompass compounds active in models of tuberculosis, SARS-CoV-2 (covid-19), and neurodegenerative diseases.


Biophagy has developed its programs in collaboration with the following outstanding institutions:

  • Sandia National Laboratories
  • New Mexico Small Business Assistance
  • University of New Mexico
  • Los Alamos National Laboratories